Literature DB >> 26800292

Early and late vulval cancer recurrences: Are they different?

Kalpana Ragupathy1, Lisa Grandidge2, Katie Strelley2, Huan Wang3, John Tidy4.   

Abstract

Vulval cancers are rare, but after primary treatment, known to recur with a high frequency (30%). Clinico-pathological predictors of recurrence have been established to a great extent. However, there is paucity of literature on predictors of early versus late recurrence. We sought to identify such predictors through a retrospective study of vulval cancer recurrences in a single cancer centre over 11 years. Age of women, depth of invasion/site of primary tumour and presence of background VIN/lichen sclerosus do not appear to affect timing of recurrence. However, vulval cancers that recur after 2 years of primary tumour recognition are more likely to be well-differentiated tumours, have undergone radical surgery and have had a closest disease-free margin >1 cm. Late recurrences are entirely local rather than distant metastases and this translates into a better survival as shown in our study (40 months median survival in the early group versus 112 in the late recurrence group).

Entities:  

Keywords:  Vulval cancer; gynaecological oncology; recurrence of vulval cancer

Mesh:

Year:  2016        PMID: 26800292     DOI: 10.3109/01443615.2015.1107529

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Cancer of the vulva: 2021 update.

Authors:  Alexander B Olawaiye; Mauricio A Cuello; Linda J Rogers
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

2.  Fertility-sparing treatment of locally advanced vulvar squamous cell carcinoma in a young patient.

Authors:  Nujsaubnusi C Vue; Nicole B Gaulin; Zachary D Horne; Sharon Liang; Thomas C Krivak
Journal:  Gynecol Oncol Rep       Date:  2022-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.